Tango Therapeutics
Antoine Simoneau holds a PhD in Molecular Biology from Université de Montréal and has a strong educational background in biochemistry. With experience as a Senior Scientist at Tango Therapeutics and as a Postdoctoral Research Fellow at Harvard Medical School and Massachusetts General Hospital, Antoine has a proven track record in the field.
Tango Therapeutics
3 followers
Tango Therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients.